15-epi-Treprostinil | CAS 343247-13-2 - Request Quote
15-epi-Treprostinil
| SZ CAT No: | SZ-T080015 |
| CAS No | 343247-13-2 |
| Mol.F. | C23H34O5 |
| Mol.Wt. | 390.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
15-epi-Treprostinil is chemically 2-(((1R,2R,3aS,9aS)-2-hydroxy-1-((R)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl)oxy)acetic acid. 15-epi-Treprostinil is supplied with detailed characterization data compliant with regulatory guideline. 15-epi-Treprostinil can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Treprostinil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 343247-13-2
Purchase 343247-13-2
Order 343247-13-2
Enquire 343247-13-2
price of 343247-13-2
343247-13-2 Supplier
343247-13-2 Manufacturer
343247-13-2 Exporter
buy high quality 15-epi-Treprostinil
Purchase 15-epi-Treprostinil
15-epi-Treprostinil suppliers
15-epi-Treprostinil manufacturers
15-epi-Treprostinil price
Order 15-epi-Treprostinil
Enquire 15-epi-Treprostinil
15-epi-Treprostinil cost
15-epi-Treprostinil Supplier
15-epi-Treprostinil Distributor
15-epi-Treprostinil for Method Validation
Treprostinil Reference Standard
15-epi-Treprostinil for ANDA Filing
15-epi-Treprostinil for Forced Degradation Studies
15-epi-Treprostinil Identification Standards
15-epi-Treprostinil for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.